X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective

X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV). Features include hemophagocytic lymphohistiocytosis (HLH), lymphomas, and dysgammaglobulinemias. Molecular cloning of the causa...

Descripción completa

Detalles Bibliográficos
Autores principales: Panchal, Neelam, Booth, Claire, Cannons, Jennifer L., Schwartzberg, Pamela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893764/
https://www.ncbi.nlm.nih.gov/pubmed/29670631
http://dx.doi.org/10.3389/fimmu.2018.00666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893764/
https://www.ncbi.nlm.nih.gov/pubmed/29670631
http://dx.doi.org/10.3389/fimmu.2018.00666

Ejemplares similares